Taizhou, China

Meidong Xu



Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2019-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Meidong Xu: Innovator in Milbemycin Production

Introduction

Meidong Xu is a notable inventor based in Taizhou, China. He has made significant contributions to the field of microbiology and pharmaceuticals, particularly in the production of milbemycin compounds. With a total of two patents to his name, Xu's work has implications for agricultural and medicinal applications.

Latest Patents

Xu's latest patents include innovative methods for producing milbemycin A4 and milbemycin A3. The first patent involves a strain of Streptomyces, specifically HS7522, which is deposited in the China General Microbiological Culture Collection Center under accession number CGMCC No. 9671 as of September 16, 2014. The second patent features another strain, HS7523, also deposited in the same center with accession number CGMCC No. 9672 on the same date. These patents highlight Xu's commitment to advancing the production methods of these important compounds.

Career Highlights

Meidong Xu is currently employed at Zhejiang Hisun Pharmaceutical Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His work at this prominent company has allowed him to focus on developing effective methods for producing vital compounds that can benefit various industries.

Collaborations

Xu collaborates with talented coworkers, including Yun Teng and Meiyi Mo. Their combined expertise contributes to the success of their projects and enhances the research environment at Zhejiang Hisun Pharmaceutical Co., Ltd.

Conclusion

Meidong Xu's contributions to the field of microbiology and pharmaceuticals, particularly through his patents on milbemycin production, demonstrate his innovative spirit and dedication to advancing scientific knowledge. His work continues to have a significant impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…